HBPL Study of the Impact of the NK1 Antagonist Aprepitant

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Jennifer Plebani, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01176591
First received: August 4, 2010
Last updated: March 8, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)